協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/02/26 | 2,110 | 2,118.5 | 2,093 | 2,108 | +19.5 | +0.9% | 1,337,100 |
2025/02/25 | 2,055 | 2,090 | 2,046 | 2,088.5 | +24.5 | +1.2% | 1,501,300 |
2025/02/21 | 2,062.5 | 2,083.5 | 2,055.5 | 2,064 | +26.5 | +1.3% | 1,358,200 |
2025/02/20 | 2,049 | 2,051.5 | 2,025 | 2,037.5 | +1 | ±0% | 965,100 |
2025/02/19 | 2,034 | 2,049.5 | 2,031 | 2,036.5 | -21 | -1% | 990,200 |
2025/02/18 | 2,045 | 2,074.5 | 2,038.5 | 2,057.5 | +4 | +0.2% | 863,300 |
2025/02/17 | 2,051 | 2,079.5 | 2,048 | 2,053.5 | -12.5 | -0.6% | 723,900 |
2025/02/14 | 2,093 | 2,105 | 2,056.5 | 2,066 | -40.5 | -1.9% | 1,335,400 |
2025/02/13 | 2,093 | 2,133 | 2,090 | 2,106.5 | +36.5 | +1.8% | 1,305,100 |
2025/02/12 | 2,076 | 2,080 | 2,045 | 2,070 | -8.5 | -0.4% | 1,706,400 |
2025/02/10 | 2,098.5 | 2,110 | 2,062.5 | 2,078.5 | -38.5 | -1.8% | 2,093,500 |
2025/02/07 | 2,135 | 2,142.5 | 2,090 | 2,117 | -123 | -5.5% | 2,813,000 |
2025/02/06 | 2,269.5 | 2,277.5 | 2,223 | 2,240 | -14 | -0.6% | 908,800 |
2025/02/05 | 2,257.5 | 2,257.5 | 2,226.5 | 2,254 | +13.5 | +0.6% | 843,500 |
2025/02/04 | 2,277 | 2,281 | 2,230.5 | 2,240.5 | +11 | +0.5% | 692,400 |
2025/02/03 | 2,280 | 2,281.5 | 2,224 | 2,229.5 | -90.5 | -3.9% | 1,229,800 |
2025/01/31 | 2,335 | 2,336.5 | 2,300 | 2,320 | -26.5 | -1.1% | 1,019,200 |
2025/01/30 | 2,328 | 2,354.5 | 2,318 | 2,346.5 | +18.5 | +0.8% | 646,800 |
2025/01/29 | 2,328.5 | 2,335.5 | 2,316 | 2,328 | -0.5 | ±0% | 540,600 |
2025/01/28 | 2,335 | 2,339.5 | 2,315.5 | 2,328.5 | +4.5 | +0.2% | 666,100 |
2025/01/27 | 2,343.5 | 2,353 | 2,319 | 2,324 | +10 | +0.4% | 633,300 |
2025/01/24 | 2,313 | 2,337.5 | 2,309.5 | 2,314 | +22 | +1% | 646,800 |
2025/01/23 | 2,274 | 2,295 | 2,257.5 | 2,292 | +4.5 | +0.2% | 696,400 |
2025/01/22 | 2,280 | 2,296.5 | 2,275.5 | 2,287.5 | +3.5 | +0.2% | 569,300 |
2025/01/21 | 2,299 | 2,301.5 | 2,275.5 | 2,284 | -10 | -0.4% | 345,800 |
2025/01/20 | 2,285 | 2,297 | 2,282 | 2,294 | +9 | +0.4% | 322,900 |
2025/01/17 | 2,283 | 2,295.5 | 2,275 | 2,285 | +2.5 | +0.1% | 656,100 |
2025/01/16 | 2,321.5 | 2,323 | 2,282.5 | 2,282.5 | -37 | -1.6% | 813,900 |
2025/01/15 | 2,356 | 2,361 | 2,317.5 | 2,319.5 | -10.5 | -0.5% | 792,600 |
2025/01/14 | 2,303.5 | 2,342 | 2,291.5 | 2,330 | +40 | +1.7% | 1,243,900 |
2025/01/10 | 2,310 | 2,319.5 | 2,283.5 | 2,290 | -30 | -1.3% | 962,300 |
2025/01/09 | 2,307 | 2,330 | 2,296.5 | 2,320 | +6 | +0.3% | 877,200 |
2025/01/08 | 2,331.5 | 2,337 | 2,314 | 2,314 | -17.5 | -0.8% | 778,600 |
2025/01/07 | 2,334 | 2,343 | 2,325.5 | 2,331.5 | +5 | +0.2% | 718,400 |
2025/01/06 | 2,374 | 2,385 | 2,317.5 | 2,326.5 | -49 | -2.1% | 1,077,200 |
2024/12/30 | 2,384.5 | 2,396 | 2,371 | 2,375.5 | -9 | -0.4% | 679,900 |
2024/12/27 | 2,362 | 2,391.5 | 2,360 | 2,384.5 | -4 | -0.2% | 833,300 |
2024/12/26 | 2,370 | 2,388.5 | 2,369.5 | 2,388.5 | +9 | +0.4% | 825,600 |
2024/12/25 | 2,390 | 2,393 | 2,369 | 2,379.5 | -6.5 | -0.3% | 519,100 |
2024/12/24 | 2,395 | 2,396.5 | 2,380 | 2,386 | +1.5 | +0.1% | 345,200 |
2024/12/23 | 2,390 | 2,392.5 | 2,366 | 2,384.5 | +9 | +0.4% | 465,100 |
2024/12/20 | 2,397.5 | 2,404.5 | 2,373.5 | 2,375.5 | -17 | -0.7% | 969,300 |
2024/12/19 | 2,370 | 2,401 | 2,369 | 2,392.5 | +10.5 | +0.4% | 682,300 |
2024/12/18 | 2,393 | 2,402.5 | 2,372.5 | 2,382 | -15 | -0.6% | 704,000 |
2024/12/17 | 2,385 | 2,417 | 2,385 | 2,397 | +12 | +0.5% | 1,063,200 |
2024/12/16 | 2,410 | 2,426.5 | 2,373 | 2,385 | -28 | -1.2% | 1,091,400 |
2024/12/13 | 2,433 | 2,456 | 2,413 | 2,413 | -43.5 | -1.8% | 1,341,800 |
2024/12/12 | 2,466 | 2,473 | 2,453 | 2,456.5 | -7.5 | -0.3% | 1,205,900 |
2024/12/11 | 2,491.5 | 2,501 | 2,451.5 | 2,464 | -19 | -0.8% | 1,068,700 |
2024/12/10 | 2,532 | 2,532 | 2,464 | 2,483 | -25 | -1% | 970,200 |
51~
100
件表示中 / 3697件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 221,800円 | -3.5% | -11.3% | 2.71% | 20.37倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 223,100円 | +20.9% | +10.6% | 2.96% | 10.55倍 | 1.39倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 399,900円 | +1.7% | -2.9% | 4.00% | 26.24倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 154,700円 | +0.6% | +43.3% | 5.17% | 10.85倍 | 0.93倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 244,100円 | +18.2% | +4.2% | 1.47% | 17.13倍 | 2.18倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム